Logo image of MARA

MARA HOLDINGS INC (MARA) Stock Fundamental Analysis

NASDAQ:MARA - US5657881067 - Common Stock

15.89 USD
-0.17 (-1.06%)
Last: 9/3/2025, 4:24:44 PM
15.85 USD
-0.04 (-0.25%)
After Hours: 9/3/2025, 4:24:44 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MARA. MARA was compared to 280 industry peers in the Software industry. Both the profitability and financial health of MARA have multiple concerns. MARA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

MARA had positive earnings in the past year.
In the past year MARA has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MARA reported negative net income in multiple years.
MARA had a negative operating cash flow in each of the past 5 years.
MARA Yearly Net Income VS EBIT VS OCF VS FCFMARA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

With an excellent Return On Assets value of 8.79%, MARA belongs to the best of the industry, outperforming 83.21% of the companies in the same industry.
MARA has a better Return On Equity (14.17%) than 80.71% of its industry peers.
Industry RankSector Rank
ROA 8.79%
ROE 14.17%
ROIC N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
MARA Yearly ROA, ROE, ROICMARA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

MARA has a Profit Margin of 85.02%. This is amongst the best in the industry. MARA outperforms 96.07% of its industry peers.
MARA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 85.02%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MARA Yearly Profit, Operating, Gross MarginsMARA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

0

2. Health

2.1 Basic Checks

MARA does not have a ROIC to compare to the WACC, probably because it is not profitable.
MARA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MARA has been increased compared to 5 years ago.
The debt/assets ratio for MARA is higher compared to a year ago.
MARA Yearly Shares OutstandingMARA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
MARA Yearly Total Debt VS Total AssetsMARA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.08, we must say that MARA is in the distress zone and has some risk of bankruptcy.
MARA has a worse Altman-Z score (1.08) than 62.86% of its industry peers.
MARA has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
MARA has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: MARA underperforms 64.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC10.37%
MARA Yearly LT Debt VS Equity VS FCFMARA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 0.54 indicates that MARA may have some problems paying its short term obligations.
MARA has a Current ratio of 0.54. This is amonst the worse of the industry: MARA underperforms 88.57% of its industry peers.
MARA has a Quick Ratio of 0.54. This is a bad value and indicates that MARA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.54, MARA is doing worse than 87.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
MARA Yearly Current Assets VS Current LiabilitesMARA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

MARA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.26%.
Looking at the last year, MARA shows a quite strong growth in Revenue. The Revenue has grown by 9.35% in the last year.
MARA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 252.85% yearly.
EPS 1Y (TTM)-32.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%362.5%
Revenue 1Y (TTM)9.35%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%64.31%

3.2 Future

Based on estimates for the next years, MARA will show a very negative growth in Earnings Per Share. The EPS will decrease by -30.89% on average per year.
MARA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.04% yearly.
EPS Next Y-57.41%
EPS Next 2Y-50.84%
EPS Next 3Y-30.89%
EPS Next 5YN/A
Revenue Next Year54.2%
Revenue Next 2Y40.77%
Revenue Next 3Y32.1%
Revenue Next 5Y8.04%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MARA Yearly Revenue VS EstimatesMARA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
MARA Yearly EPS VS EstimatesMARA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.13 indicates a correct valuation of MARA.
82.86% of the companies in the same industry are more expensive than MARA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MARA to the average of the S&P500 Index (26.90), we can say MARA is valued slightly cheaper.
MARA is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 15.13
Fwd PE N/A
MARA Price Earnings VS Forward Price EarningsMARA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MARA Per share dataMARA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A cheap valuation may be justified as MARA's earnings are expected to decrease with -30.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-50.84%
EPS Next 3Y-30.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MARA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARA HOLDINGS INC

NASDAQ:MARA (9/3/2025, 4:24:44 PM)

After market: 15.85 -0.04 (-0.25%)

15.89

-0.17 (-1.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners58.67%
Inst Owner Change7.5%
Ins Owners0.65%
Ins Owner Change-4.9%
Market Cap5.89B
Analysts74.29
Price Target21.79 (37.13%)
Short Float %28.49%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1988.84%
Min EPS beat(2)-4177.95%
Max EPS beat(2)200.28%
EPS beat(4)2
Avg EPS beat(4)-1006.45%
Min EPS beat(4)-4177.95%
Max EPS beat(4)200.28%
EPS beat(8)5
Avg EPS beat(8)-168.87%
EPS beat(12)6
Avg EPS beat(12)-141.67%
EPS beat(16)6
Avg EPS beat(16)-173.5%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-6.36%
Max Revenue beat(2)5.37%
Revenue beat(4)2
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-14.9%
Max Revenue beat(4)12.77%
Revenue beat(8)3
Avg Revenue beat(8)-2.93%
Revenue beat(12)4
Avg Revenue beat(12)-7.58%
Revenue beat(16)5
Avg Revenue beat(16)-9.11%
PT rev (1m)5.72%
PT rev (3m)7.72%
EPS NQ rev (1m)7.35%
EPS NQ rev (3m)630.59%
EPS NY rev (1m)2068.91%
EPS NY rev (3m)5259.66%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)-7.69%
Revenue NY rev (1m)4.58%
Revenue NY rev (3m)4.26%
Valuation
Industry RankSector Rank
PE 15.13
Fwd PE N/A
P/S 7.37
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)1.05
EY6.61%
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)-2.3
OCFYN/A
SpS2.16
BVpS12.93
TBVpS12.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 14.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 85.02%
GM N/A
FCFM N/A
ROA(3y)-12.16%
ROA(5y)-8.47%
ROE(3y)-49.6%
ROE(5y)-31.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.98%
Cap/Sales 48.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 1.08
F-Score1
WACC10.37%
ROIC/WACCN/A
Cap/Depr(3y)247.24%
Cap/Depr(5y)1644.95%
Cap/Sales(3y)163.79%
Cap/Sales(5y)566.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%362.5%
EPS Next Y-57.41%
EPS Next 2Y-50.84%
EPS Next 3Y-30.89%
EPS Next 5YN/A
Revenue 1Y (TTM)9.35%
Revenue growth 3Y60.35%
Revenue growth 5Y252.85%
Sales Q2Q%64.31%
Revenue Next Year54.2%
Revenue Next 2Y40.77%
Revenue Next 3Y32.1%
Revenue Next 5Y8.04%
EBIT growth 1Y-75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.14%
EBIT Next 3Y43.14%
EBIT Next 5Y-37.28%
FCF growth 1Y-195.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-206.1%
OCF growth 3YN/A
OCF growth 5YN/A